Association between antihypertensive medication use and non-cardiovascular outcomes in older men

Journal of General Internal Medicine

Volumn 22, Issue 12, 2007, Pages 1661-1667

  Agostini, Joseph V ^a,b   Tinetti, Mary E ^b   Han, Ling ^b   Peduzzi, Peter ^a,b   Foody, Joanne M ^b   Concato, John ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adverse effects; Aged; Ambulatory care; Antihypertensives; Drugs; Polypharmacy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL MUSCLE RELAXANT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ARTICLE; BLOOD PRESSURE; CHAIR; COGNITION; COHORT ANALYSIS; COMMUNITY; COMORBIDITY; CONFIDENCE INTERVAL; CONFOUNDING VARIABLE; DEPRESSION; DRUG USE; FOLLOW UP; HEALTH BEHAVIOR; HUMAN; HYPERTENSION; MALE; MOOD; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PHYSICAL PERFORMANCE; PHYSICIAN; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; PSYCHOLOGIC TEST; SCORING SYSTEM; TIME; VETERAN;

AGED; ANTI-INFECTIVE AGENTS; COGNITION; COMORBIDITY; DEPRESSION; DRUG THERAPY, COMBINATION; HEALTH BEHAVIOR; HUMANS; HYPERTENSION; MALE; MOTOR ACTIVITY; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 36348990708     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-007-0388-9     Document Type: Article

References (47)

1. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363-9.
2. Brown MJ, Cruickshank JK, Dominiczak AF, et al. Better blood pressure control: how to combine drugs. J Hum Hypertens. 2003;17:81-6.
3. Anonymous. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-46.
4. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med. 2004;164:722-32.
5. Agostini JV, Han L, Tinetti ME. The relationship between number of medications and weight loss or impaired balance in older adults. J Am Geriatr Soc. 2004;52:1719-23.
6. Huang SM, Lesko LJ. Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned? J Clin Pharmacol. 2004;44:559-69.
7. Onder G, Penninx BW, Balkrishnan R, et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet. 2002;359:926-30.
8. Imai Y, Watanabe N, Hashimoto J, et al. Muscle cramps and elevated serum creatine phosphokinase levels induced by beta-adrenoceptor blockers. Eur J Clin Pharmacol. 1995;48:29-34.
9. Mosenkis A, Townsend RR. Muscle cramps and diuretic therapy. J Clin Hypertens (Greenwich). 2005;7:134-5.
10. Chen K, Chiou CF, Plauschinat CA, et al. Patient satisfaction with antihypertensive therapy. J Hum Hypertens. 2005;19:793-9.
11. Cheung BM, Wong YL, Lau CP. Queen Mary utilization of antihypertensive drugs study: side-effects of antihypertensive drugs. J Clin Pharm Ther. 2005;30:391-9.
12. Prince MJ, Bird AS, Blizard RA, et al. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. BMJ. 1996;312:801-5.
13. Anonymous. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265:3255-64.
14. Applegate WB, Pressel S, Wittes J, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med. 1994;154:2154-60.
15. Reid MC, Boutros NN, O'Connor PG, et al. The health-related effects of alcohol use in older persons: a systematic review. Subst Abuse. 2002;23:149-64.
16. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992;41:237-48.
17. Fillenbaum GG. Multidimensional Functional Assessment of Older Adults: The Duke Older Americans Resources and Services Procedures. Hillsdale, NJ: Erlbaum; 1988.
18. Pahor M, Chrischilles EA, Guralnik JM, et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol. 1994;10:405-11.
19. American Hospital Formulary Service. Drug Information. Bethesda, MD: American Society of Hospital Pharmacists; 1994.
20. Birns J, Kalra L. Blood pressure and vascular cognitive impairment: the debate continues. J Hum Hypertens. 2006;20:1-3.
21. Thiessen BQ, Wallace SM, Blackburn JL, et al. Increased prescribing of antidepressants subsequent to beta-blocker therapy. Arch Intern Med. 1990;150:2286-90.
22. Guralnik JM, Ferrucci L, Simonsick EM, et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556-61.
23. Vickers D, Vincent N, Medvedev A. The geometric structure, construction, and interpretation of path-following (trail-making) tests. J Clin Psychol. 1996;52:651-61.
24. Kohout FJ, Berkman LF, Evans DA, et al. Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health. 1993;5:179-93.
25. SAS. SAS Version 9.1. Cary, NC: SAS Institute Inc.; 2003.
26. Fleiss J. The comparison of proportions from several independent samples. In: Statistical Methods for Rates and Proportions, 2nd ed. New York, NY: Wiley; 1981:143-6.
27. Allison PD. Missing Data. Sage University Papers on Quantitative Applications in the Social Sciences, 07-136. Thousand Oaks, CA: Sage; 2001:27-87.
28. Lee PY, Alexander KP, Hammill BG, et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA. 2001;286:708-13.
29. Fried TR, Bradley EH, Towle VR, et al. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002;346:1061-6.
30. Committee on the Assessment of the US Drug Safety System, Baciu A, Stratton K, Burke SPa, eds. The Future of Drug Safety: Promoting and Protecting the Health of the Public. Washington, D.C.: The National Academies Press; 2006.
31. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85-94.
32. Davis JW, Ross PD, Nevitt MC, et al. Risk factors for falls and for serious injuries on falling among older Japanese women in Hawaii. J Am Geriatr Soc. 1999;47:792-8.
33. de Rekeneire N, Visser M, Peila R, et al. Is a fall just a fall: correlates of falling in healthy older persons. The Health, Aging and Body Composition Study. J Am Geriatr Soc. 2003;51:841-6.
34. Di Bari M, van de Poll-Franse LV, Onder G, et al. Antihypertensive medications and differences in muscle mass in older persons: the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2004;52:961-6.
35. Gambassi G, Lapane KL, Sgadari A, et al. Effects of angiotensin- converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. Arch Intern Med. 2000;160:53-60.
36. Rantanen T, Avlund K, Suominen H, et al. Muscle strength as a predictor of onset of ADL dependence in people aged 75 years. Aging Clin Exp Res. 2002;14:10-5.
37. Rantanen T, Guralnik JM, Sakari-Rantala R, et al. Disability, physical activity, and muscle strength in older women: the Women's Health and Aging Study. Arch Phys Med Rehabil. 1999;80:130-5.
38. Laukkanen P, Heikkinen E, Kauppinen M. Muscle strength and mobility as predictors of survival in 75-84-year-old people. Age Ageing. 1995;24:468-73.
39. Weir MR, Prisant LM, Papademetriou V, et al. Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy. Am J Hypertens. 1996;9:854-9.
40. Lewis DK, Robinson J, Wilkinson E. Factors involved in deciding to start preventive treatment: qualitative study of clinicians' and lay people's attitudes. BMJ. 2003;327:841.
41. Muldoon MF, Waldstein SR, Jennings JR. Neuropsychological consequences of antihypertensive medication use. Exp Aging Res. 1995;21:353-68.
42. Forette F, Seux ML, Staessen JA, et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002;162:2046-52.
43. Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163:1069-75.
44. Ko DT, Hebert PR, Coffey CS, et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002;288:351-7.
45. Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA. 1986;255:357-60.
46. Hullett FJ, Potkin SG, Levy AB, et al. Depression associated with nifedipine-induced calcium channel blockade. Am J Psychiatry. 1988;145:1277-9.
47. Eccleston D, Cole AJ. Calcium-channel blockade and depressive illness. Br J Psychiatry. 1990;156:889-91.